Coquart, PaulinePaulineCoquartEl Haddad, AndreaAndreaEl HaddadKoutsouras, DimitriosDimitriosKoutsourasBolander, JohannaJohannaBolander2025-05-082025-05-0820251873-4219WOS:001477217600001https://imec-publications.be/handle/20.500.12860/45613The growing burden of degenerative, cardiovascular, neurodegenerative, and cancerous diseases necessitates innovative approaches to improve our pathophysiological understanding and ability to modulate biological processes. Organic bioelectronics has emerged as a powerful tool in this pursuit, offering a unique ability to interact with biology due to the mixed ionic–electronic conduction and tissue-mimetic mechanical properties of conducting polymers (CPs). These materials enable seamless integration with biological systems across different levels of complexity, from monolayers to complex 3D models, microfluidic chips, and even clinical applications. CPs can be processed into diverse formats, including thin films, hydrogels, 3D scaffolds, and electrospun fibers, allowing the fabrication of advanced bioelectronic devices such as multi-electrode arrays, transistors (EGOFETs, OECTs), ion pumps, and photoactuators. This review examines the integration of CP-based bioelectronics in vivo and in in vitro microphysiological systems, focusing on their ability to monitor key biological events, including electrical activity, metabolic changes, and biomarker concentrations, as well as their potential for electrical, mechanical, and chemical stimulation. We highlight the versatility and biocompatibility of CPs and their role in advancing personalized medicine and regenerative therapies and discuss future directions for organic bioelectronics to bridge the gap between biological systems and electronic technologies.Journal article review10.3390/bios15040253WOS:001477217600001CONDUCTING POLYMERSELECTROCHEMICAL TRANSISTORSMICROELECTRODE ARRAYSYOUNGS MODULUSPEDOTPSS FILMSIN-VITROBIOCOMPATIBILITYPOLYPYRROLECOMPOSITESMOBILITYMEDLINE:40277566